JAK Inhibitors in RA: Applying Evidence-Based Strategies in Clinical Decision-making

Hear from the experts as they highlight the latest clinical trial and real-world evidence regarding JAK inhibitor efficacy and safety to help contextualize risks and apply practical mitigation strategies to comprehensive care plans.

Vivian P. Bykerk, MD, FRCPC Stanley B. Cohen, MD Janet Pope, MD, MPH, FRCPC Vibeke Strand, MD, MACR, FACP Released: January 9, 2023